Oragenics Inc. (NYSE AMERICAN: OGEN)
$1.14
-0.0450 ( -3.81% ) 58.9K
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
Market Data
Open
$1.14
Previous close
$1.18
Volume
58.9K
Market cap
$6.31M
Day range
$1.13 - $1.20
52 week range
$0.97 - $7.74
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jul 10, 2024 |
8-k | 8K-related | 20 | Jun 26, 2024 |
8-k | 8K-related | 14 | Jun 20, 2024 |
8-k | 8K-related | 13 | May 23, 2024 |
8-k | 8K-related | 15 | May 22, 2024 |
8-k | 8K-related | 14 | May 17, 2024 |
8-k | 8K-related | 14 | May 16, 2024 |
10-q | Quarterly Reports | 54 | May 15, 2024 |
8-k | 8K-related | 14 | May 07, 2024 |
8-k | 8K-related | 14 | Apr 22, 2024 |